OXFORD BIOSCIENCE PARTNERS
Oxford Bioscience Partners (OBP), established in 1992, is a venture capital firm that provides equity financing and management assistance to emerging, entrepreneurial-driven companies within the life sciences and healthcare sectors. While willing to consider an investment in a company at almost any stage, OBP primarily works with early-stage situations. With approximately $1B of committed capital under management, OBP has invested in over 140 life science companies worldwide.
OXFORD BIOSCIENCE PARTNERS
Industry:
Biotechnology Financial Services Health Care Pharmaceutical
Founded:
1992-01-01
Status:
Active
Contact:
(617) 357-7474
Email Addresses:
[email protected]
Technology used in webpage:
Google Font API Font Awesome Domain Not Resolving Google Maps AJAX Libraries API Google Maps API Cloudflare Hosting Cloudflare DNS WooCommerce ThemePunch
Similar Organizations
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Underscore VC
Underscore VC is a venture capital firm backing entrepreneurs from Seed to Series A.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-09-27 | Paperspace | Oxford Bioscience Partners investment in Series F - Paperspace | 0 BRL |
| 2017-01-01 | Yolia Health | Oxford Bioscience Partners investment in Series A - Yolia Health | 3 M USD |
| 2014-05-09 | CardioFocus | Oxford Bioscience Partners investment in Debt Financing - CardioFocus | 2.38 M USD |
| 2013-09-11 | Affinium Pharmaceuticals | Oxford Bioscience Partners investment in Debt Financing - Affinium Pharmaceuticals | 11.9 M USD |
| 2013-07-31 | Dicerna Pharmaceuticals | Oxford Bioscience Partners investment in Series C - Dicerna Pharmaceuticals | 60 M USD |
| 2012-05-16 | Mitralign | Oxford Bioscience Partners investment in Series D - Mitralign | 35 M USD |
| 2012-01-24 | Glori Energy | Oxford Bioscience Partners investment in Series C - Glori Energy | 20 M USD |
| 2011-02-28 | CardioFocus | Oxford Bioscience Partners investment in Series C - CardioFocus | 30.6 M USD |
| 2010-09-07 | SuperDimension | Oxford Bioscience Partners investment in Venture Round - SuperDimension | 9.8 M USD |
| 2010-09-07 | SuperDimension | Oxford Bioscience Partners investment in Debt Financing - SuperDimension | 15 M USD |